LY3493269

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for LY3493269, covering 2025-01-14 to 2025-01-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3493269 in Participants With Type 2 Diabetes [Phase 1]